Harvard Bioscience Schedules Fourth Quarter 2018 Conference Call for February 28 at 4:30 PM ET
19 févr. 2019 16h05 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will...
Harvard Bioscience Presents Data, Symposium Session and New Products at Neuroscience 2018
02 nov. 2018 14h30 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is...
Harvard Bioscience Reports Third Quarter 2018 Financial Results
25 oct. 2018 16h02 HE
|
Harvard Bioscience, Inc.
-Reports GAAP and adjusted non-GAAP revenue of $28.6 million and $28.7 million, respectively, an increase of 53% and 15%, respectively- HOLLISTON, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Harvard...
Harvard Bioscience Names Kam Unninayar as Chief Financial Officer
22 oct. 2018 16h11 HE
|
Harvard Bioscience, Inc.
Seasoned Financial Executive With More Than a Decade in Global Life Science Instrumentation, Will Begin on November 26 HOLLISTON, Mass., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience,...
Harvard Bioscience Schedules Third Quarter 2018 Conference Call for October 25 at 4:30 PM ET
18 oct. 2018 16h30 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will...
Harvard Bioscience Announces Management Change
22 août 2018 08h30 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance...
Harvard Bioscience Reports Second Quarter 2018 Financial Results
26 juil. 2018 16h01 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance...
Harvard Bioscience Schedules Second Quarter 2018 Conference Call for July 26 at 4:30 PM ET
19 juil. 2018 09h00 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., July 19, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will...
Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants For Measuring Continuous Blood Glucose
20 juin 2018 16h01 HE
|
Harvard Bioscience, Inc.
ST. PAUL, Minn. and HOLLISTON, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of Harvard Bioscience, Inc. (Nasdaq:HBIO) and the global leader in wireless...
Harvard Bioscience Subsidiary Data Sciences International Launches Inhalation Exposure System
13 juin 2018 16h01 HE
|
Harvard Bioscience, Inc.
ST. PAUL, Minn. and HOLLISTON, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of Harvard Bioscience, Inc. (Nasdaq:HBIO) launched a new inhalation and...